- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Mitochondrial uncoupling protein as a target of pharmacotherapy for obesity.
-
- SAITO Masayuki
- Department of Biomedical Sciences, Graduate School of Veterinary Medicine, Hokkaido University
-
- OHASHI Atsuko
- Department of Biomedical Sciences, Graduate School of Veterinary Medicine, Hokkaido University
Bibliographic Information
- Other Title
-
- 抗肥満創薬のターゲットとしてのミトコンドリア脱共役タンパク質UPC
- 抗肥満創薬のターゲットとしてのミトコンドリア脱共役タンパク質UCP
- コウヒマンソウヤク ノ ターゲット ト シテ ノ ミトコンドリア ダツキョウヤク タンパクシツ UCP
Search this article
Description
Uncoupling protein (UCP) is a transporter family present in the mitochondrial inner membrane, and as its name suggests, it uncouples respiration from ATP synthesis by dissipating the transmembrane proton gradient as heat. UCP is now recognized as a key molecule in metabolic thermogenesis such as cold- and diet-induced heat production, which is a significant component of energy expenditure, and its dysfunction contributes to the development of obesity. Among the UCP family, UCP-1 is expressed exclusively in brown adipose tissue (BAT), while UCP-2 is present in many organs and UCP-3 is in skeletal muscle. BAT thermogenesis by UCP-1, which has been studied most extensively, is controlled directly by sympathetic nerves principally through the β-adrenergic action of norepinephrine. Since the β3-adrenoceptor is present primarily in adipose tissues, its selective agonists stimulate BAT thermogenesis and also lipid mobilization in white adipose tissue without any noticeable effect on β1-and β2-adrenoceptos. Therefore, β3-adrenoceptor agonists would be promising for the pharmacotherapy of obesity. UCP gene expression is up regulated by ligands for nuclear receptors such as thyroid hormone receptor, peroxisome proliferator-activated receptors (PPAR) and retinoid-X receptor. Long chain fatty acids and some of their metabolites are known to activate PPAR and thereby lead to abundant expression of UCP, which may also contribute to increase in energy expenditure and prevention of obesity. The activity of UCP is suppressed by purine nucleotides but activated by fatty acids. Thus, fatty acids increase UCP-mediated thermogenesis by direct activation of UCP and also by increased gene expression, implying some specific fatty acids or their derivatives as an effactive anti-obesity tool.
Journal
-
- Folia Pharmacologica Japonica
-
Folia Pharmacologica Japonica 118 (5), 327-333, 2001
The Japanese Pharmacological Society
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679248216576
-
- NII Article ID
- 10007943850
-
- NII Book ID
- AN00198335
-
- COI
- 1:CAS:528:DC%2BD3MXosVOjsb4%3D
-
- ISSN
- 13478397
- 00155691
-
- NDL BIB ID
- 5955136
-
- PubMed
- 11729636
-
- Text Lang
- ja
-
- Article Type
- journal article
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- PubMed
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed